ArticlePsychopharmacology2026
Abnormal dynamics of brain networks in bipolar disorder: a dynamic degree centrality and imaging-transcriptomic investigation.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundBipolar disorder (BD) is a chronic psychiatric illness with high recurrence and disability rates. Identifying neuroimaging biomarkers may improve diagnostic precision and treatment prediction.
methodsThe resting-state functional MRI (rs-fMRI) data were acquired from patients with BD and age-, sex-, and education-matched healthy controls (HCs), with a subset of patients completing a three-month pharmacological follow-up. Dynamic degree centrality (dDC) was calculated using a sliding-window approach to characterize time-varying whole-brain network integration. Group differences were assessed at baseline and post-treatment. Support vector machine (SVM) models were used to evaluate the discriminative ability of dDC features. Imaging–transcriptomic association analyses were conducted using gene expression data from the Allen Human Brain Atlas to explore potential molecular mechanisms.
resultsCompared with HCs, patients with BD at baseline showed significantly reduced dDC variability in the cerebellar Crus I and Crus II. After treatment, increased dDC variability emerged in the bilateral anterior cingulate and paracingulate gyri. The SVM classifier based on dDC features achieved moderate performance in distinguishing BD patients from HCs. Transcriptomic analyses indicated that genes associated with dDC alterations were mainly enriched in synaptic signaling and immune–inflammatory pathways, with several hub genes identified in protein–protein interaction networks.
conclusionBD is characterized by disrupted temporal dynamics of whole-brain network integration involving cerebellar and cingulate regions, which appear partially modulated by pharmacological treatment. Integrating dynamic network metrics with transcriptomic data provides complementary insights into the neurobiological and molecular substrates of BD and supports the potential of dDC as a neuroimaging biomarker.
Indexed as
Identifiers
42026312What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.